Long-Acting Cabotegravir and Rilpivirine for Maintenance of HIV-1 Suppression | Zendy

Susan Swindells | Zendy; Jaime AndradeVillanueva | Zendy; Gary Richmond | Zendy; Giuliano Rizzardini | Zendy; Axel Baumgarten | Zendy; Mar Masiá | Zendy; Gulam Latiff | Zendy; Vadim Pokrovsky | Zendy; Fritz Bredeek | Zendy; Graham Smith | Zendy; Pedro Cahn | Zendy; Kim Ys | Zendy; Susan L. Ford | Zendy; Christine L. Talarico | Zendy; Parul Patel | Zendy; Vasiliki Chounta | Zendy; Herta Crauwels | Zendy; Wim Parys | Zendy; Simon Vanveggel | Zendy; Joseph Mrus | Zendy; Jenny Huang | Zendy; Conn Harrington | Zendy; Krischan J Hudson | Zendy; David A. Margolis | Zendy; Kimberly Y. Smith | Zendy; Peter Williams | Zendy; William Spreen | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Long-Acting Cabotegravir and Rilpivirine for Maintenance of HIV-1 Suppression

Author(s) -

Susan Swindells,

Jaime AndradeVillanueva,

Gary Richmond,

Giuliano Rizzardini,

Axel Baumgarten,

Mar Masiá,

Gulam Latiff,

Vadim Pokrovsky,

Fritz Bredeek,

Graham Smith,

Pedro Cahn,

Kim Ys,

Susan L. Ford,

Christine L. Talarico,

Parul Patel,

Vasiliki Chounta,

Herta Crauwels,

Wim Parys,

Simon Vanveggel,

Joseph Mrus,

Jenny Huang,

Conn Harrington,

Krischan J Hudson,

David A. Margolis,

Kimberly Y. Smith,

Peter Williams,

William Spreen

Publication year - 2020

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa1904398

Subject(s) - rilpivirine , medicine , confidence interval , liter , clinical endpoint , reverse transcriptase inhibitor , human immunodeficiency virus (hiv) , integrase inhibitor , pharmacotherapy , viral load , randomized controlled trial , antiretroviral therapy , virology

Simplified regimens for the treatment of human immunodeficiency virus type 1 (HIV-1) infection may increase patient satisfaction and facilitate adherence.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research